Wargacki Stephen 4/A
4/A · Aquestive Therapeutics, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4/AAmended
Wargacki Stephen
Chief Science Officer
Transactions
- Tax Payment
Common Stock
2024-03-09$4.88/sh−19,505$95,184→ 261,414 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .